This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Jazz Pharmaceuticals Therapeutics, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Philippe Legros: Innovator in Liposomal Formulations
Introduction
Philippe Legros is a notable inventor based in Burnaby, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of liposomal formulations.
Latest Patents
Philippe Legros holds a patent for "Liposomal formulations of Bcl inhibitors." This patent includes liposomes comprising B-cell lymphoma (Bcl) protein inhibitors, compositions that utilize these liposomes, and methods for using such formulations to treat hyperproliferative disorders. He has 1 patent to his name.
Career Highlights
Philippe Legros is currently employed at Jazz Pharmaceuticals Therapeutics, Inc., where he continues to innovate in the pharmaceutical industry. His work focuses on developing advanced therapeutic solutions that can improve patient outcomes.
Collaborations
He has collaborated with notable colleagues such as Paul Tardi and Leon Wan, contributing to a dynamic research environment that fosters innovation.
Conclusion
Philippe Legros is a distinguished inventor whose work in liposomal formulations has the potential to impact the treatment of various disorders. His contributions to the field exemplify the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile